CPHA Canvax
CPHA Canvax

"COVID vaccines have been approved in Canada for youth and adults 12 and older. The National Advisory Committee on Immunization (NACI, 2021) recommends that (with very few exceptions) that a complete series with a Pfizer-BioNTech COVID-19 vaccine should be offered to individuals 12 to 18 years of age. While Pfizer recently announced a COVID vaccine trial involving children aged 6 months to 11 years, most children younger than 12 are not likely to be vaccinated in Canada until late winter or early spring 2022 (Dailey, 2021; Global News, 2021). Studies are underway to develop and test vaccines for those younger children." - Children's Healthcare Canada

Web link

The COVID-19 Vaccine and Canada's Children and Youth

Related Resources


Background Knowledge



Vaccine Safety and Development,Vaccine Safety,Vaccine Safety,Specific Populations,Children,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Vaccine Safety
Vaccine Safety
Specific Populations
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.